Patent ID: 9708307
Date: 2017-07-18
CPC Classifications: A61P,C07D

Claim:
1. A method for treating a disease selected from the group consisting of: (1) a negative symptom of schizophrenia; (2) Parkinson's disease; and (3) Huntington's disease, comprising administering to a subject in need thereof an effective amount of a compound or a salt thereof selected from the group consisting of: 2-(5-chloro-2-oxo-1,3-benzoxazol-3(2H)-yl)-N-methyl-N-{[5-(trifluoromethyl)-1H-benzimidazol-2-yl]methyl}acetamide, N-[(5-chloro-1H-benzimidazol-2-yl)methyl]-2-(5-chloro-2-oxo-1,3-benzoxazol-3(2H)-yl)-N-methylacetamide, 2-(5-chloro-4-fluoro-2-oxo-1,3-benzoxazol-3 (2H)-yl)-N-methyl-N-{[5-(trifluoromethyl)-1H-benzimidazol-2-yl]methyl}acetamide, N-[(5-bromo-1H-benzimidazol-2-yl)methyl]-2-(5-chloro-2-oxo-1,3-benzoxazol-3(2H)-yl)-N-methylacetamide, and N-[(5-chloro-1H-benzimidazol-2-yl)methyl]-N-methyl-2-[2-oxo-5-(trifluoromethyl)-1,3-benzoxazol-3(2H)-yl]acetamide, or a salt thereof.